Reviews
Description
Ch. 1: Changes in Guideline Trends and Applications in Practice: JNC 2013 and the future
Hala Yamout
George L. Bakris
Ch. 2: Central BP monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD
Debbie L. Cohen
Yonghong Huan
Raymond R. Townsend
Ch. 3: Resistant hypertension in patients with chronic kidney disease
Mohsin Wali
Sudhir R. Naik
C. Venkata S. Ram
Ch. 4: Neurogenic Factors In Hypertension Associated With Chronic Kidney Disease
Vito M. Campese
Ch. 5: Novel Molecules
Valeria Lourdes Vukelic
Marcelo Orias
Ch. 6: Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?
Domenic A. Sica
Ch. 7: Renal Sympathetic Denervation
Markus P. Schlaich
Ch. 8: Novel baroreceptor activation therapy
Peter W. de Leeuw
Abraham A. Kroon
Ch. 9: Blood Pressure Vaccines
Sorot Phisitkul
Joel Topf
Ch. 10: Masked Hypertension: Does it Lead to CVD or CKD?
F. Wilford Germino
Ch. 11: White Coat Hypertension- Do We Really Understand It Now?
Luis M. Ruilope
Ch. 12: Uric Acid And Hypertension - Is There Really A Link?
Anuradha Wadhwa
Shinichiro Inaba
Richard J. Johnson
Ch. 13: Preeclampsia: Angiogenic factors, blood pressure, and the kidney
Frank T. Spradley
Eric Matthew George
Ana Carolina Palei
Junie Paula Warrington
Joey P. Granger
Ch.14: Inflammation and Hypertension
Paolo Pauletto
Marcello Rattazzi
Ch. 15: Genome-Wide Association Studies (Gwas) Of Blood Pressure In Different Populations
Srividya Kidambi
Theodore A. Kotchen
Ch. 16: Endocrine Hypertension and Chronic Kidney Disease
Christian A. Koch
Christina Pamporaki
Vitaly Kantorovich
Ch. 17: Hypertension in Children with Chronic Kidney Disease
Douglas L. Blowey
Bradley A. Warady
Ch. 18: Obesity/OSA/Metabolic syndrome in pts with CKD and hypertension-the missing link
Mugurel Apetrii
Luminita VoroneanuAdrian C. Covic
EXTRA 10 % discount with code: EXTRA
The promotion ends in 17d.14:09:53
The discount code is valid when purchasing from 10 €. Discounts do not stack.
Ch. 1: Changes in Guideline Trends and Applications in Practice: JNC 2013 and the future
Hala Yamout
George L. Bakris
Ch. 2: Central BP monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD
Debbie L. Cohen
Yonghong Huan
Raymond R. Townsend
Ch. 3: Resistant hypertension in patients with chronic kidney disease
Mohsin Wali
Sudhir R. Naik
C. Venkata S. Ram
Ch. 4: Neurogenic Factors In Hypertension Associated With Chronic Kidney Disease
Vito M. Campese
Ch. 5: Novel Molecules
Valeria Lourdes Vukelic
Marcelo Orias
Ch. 6: Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?
Domenic A. Sica
Ch. 7: Renal Sympathetic Denervation
Markus P. Schlaich
Ch. 8: Novel baroreceptor activation therapy
Peter W. de Leeuw
Abraham A. Kroon
Ch. 9: Blood Pressure Vaccines
Sorot Phisitkul
Joel Topf
Ch. 10: Masked Hypertension: Does it Lead to CVD or CKD?
F. Wilford Germino
Ch. 11: White Coat Hypertension- Do We Really Understand It Now?
Luis M. Ruilope
Ch. 12: Uric Acid And Hypertension - Is There Really A Link?
Anuradha Wadhwa
Shinichiro Inaba
Richard J. Johnson
Ch. 13: Preeclampsia: Angiogenic factors, blood pressure, and the kidney
Frank T. Spradley
Eric Matthew George
Ana Carolina Palei
Junie Paula Warrington
Joey P. Granger
Ch.14: Inflammation and Hypertension
Paolo Pauletto
Marcello Rattazzi
Ch. 15: Genome-Wide Association Studies (Gwas) Of Blood Pressure In Different Populations
Srividya Kidambi
Theodore A. Kotchen
Ch. 16: Endocrine Hypertension and Chronic Kidney Disease
Christian A. Koch
Christina Pamporaki
Vitaly Kantorovich
Ch. 17: Hypertension in Children with Chronic Kidney Disease
Douglas L. Blowey
Bradley A. Warady
Ch. 18: Obesity/OSA/Metabolic syndrome in pts with CKD and hypertension-the missing link
Mugurel Apetrii
Luminita VoroneanuAdrian C. Covic
Reviews